Vardenafil (2 Offers)

What Is Vardenafil?

Vardenafil is a prescription medicine belonging to the phosphodiesterase type 5 (PDE5) inhibitor class. Its established medical use is the treatment of erectile dysfunction in adult men.

Vardenafil is not Testosterone, an anabolic steroid or a hormone-replacement product. Its effect on erectile function comes from changes in vascular signaling rather than from directly increasing androgen levels.

Vardenafil, Levitra & Staxyn

Vardenafil identifies the active pharmaceutical ingredient. Levitra is a well-known brand name associated with conventional Vardenafil tablets, while Staxyn has been associated with an orally disintegrating Vardenafil formulation.

Generic and manufacturer-specific products can use different branding and package configurations while containing the same underlying active substance.

Dosage form matters, however, because conventional film-coated tablets and orally disintegrating formulations should not automatically be treated as identical product formats.

How Does Vardenafil Work?

During sexual stimulation, nitric oxide signaling promotes formation of cyclic guanosine monophosphate (cGMP) within erectile tissue. cGMP contributes to smooth-muscle relaxation and increased penile blood flow.

PDE5 normally breaks down cGMP. Vardenafil inhibits PDE5, allowing this signaling to persist longer and supporting the physiological erectile response when sexual stimulation occurs.

Vardenafil therefore does not simply produce an erection independently of stimulation and should not be confused with a medicine intended primarily to increase libido.

Vardenafil & Erectile Dysfunction

Vardenafil is indicated for the treatment of erectile dysfunction (ED). Erectile dysfunction refers to persistent difficulty achieving or maintaining an erection sufficient for sexual activity.

ED can have many potential causes, including cardiovascular disease, diabetes, neurological disorders, medications, psychological factors and hormonal conditions.

A PDE5 inhibitor can improve erectile function without necessarily correcting the underlying cause. Persistent or newly developing erectile dysfunction can therefore warrant appropriate medical evaluation.

Timing Characteristics

Conventional Vardenafil tablets are generally described in current U.S. prescribing information as being taken before anticipated sexual activity, with sexual stimulation still required for a response.

Timing and individual response can vary according to health status, food intake, other medicines and individual physiology. The timing characteristics of Vardenafil should not automatically be applied to Sildenafil, Tadalafil or Avanafil.

Different dosage forms may also have product-specific administration instructions, making the exact formulation important when reviewing a listing.

Vardenafil vs. Sildenafil

Vardenafil and Sildenafil are both PDE5 inhibitors used for erectile dysfunction and have broadly similar therapeutic roles, but they are separate active pharmaceutical ingredients.

Sildenafil is widely associated with Viagra, while Vardenafil is associated with Levitra. Their metabolism, labeled strengths, interaction profiles and individual tolerability can differ.

They should therefore be compared as distinct medicines rather than assumed to be interchangeable simply because both inhibit PDE5.

Vardenafil vs. Tadalafil

Vardenafil and Tadalafil belong to the same PDE5 inhibitor class but differ significantly in duration characteristics.

Tadalafil is particularly known for its long elimination half-life and extended pharmacological window. Vardenafil generally has a shorter duration and different timing profile.

This does not mean that one medicine is universally preferable. Individual suitability depends on medical history, other medicines, desired treatment characteristics and tolerability.

Vardenafil vs. Avanafil

Vardenafil and Avanafil both inhibit PDE5, but they have distinct pharmacokinetic and product characteristics.

Avanafil is particularly associated with a relatively rapid onset option, while Vardenafil has its own timing, metabolism and safety considerations.

The actual active ingredient should therefore remain the starting point when comparing PDE5 inhibitor products rather than considering every ED tablet an equivalent substitute.

Comparing Vardenafil Products

When browsing Vardenafil products, useful comparison points include the labeled amount per tablet, dosage form, total tablet count, manufacturer, current price, warehouse location and published laboratory testing where available.

Products containing Vardenafil can differ in tablet strength, package quantity and manufacturer-specific presentation. Reviewing the complete product specification provides a clearer comparison than relying on branding or price alone.

Tablet Strength vs. Package Quantity

The labeled mg-per-tablet strength identifies the amount of Vardenafil stated in each tablet. Package quantity separately identifies the total number of tablets supplied.

Two Vardenafil products can therefore contain the same active ingredient while differing in tablet strength, dosage form or package quantity. Check these specifications individually when comparing available products.

Published Vardenafil Lab Reports

Selected Vardenafil products may have published laboratory reports that provide an additional reference point when comparing the labeled specification with the measured result reported for a submitted sample.

Where testing is available, review the identified active substance, measured result, testing date and reported batch number. If multiple reports have been published, results from different batches or testing dates can be reviewed individually.

Each laboratory report applies to the submitted sample identified in that analysis. A result from one sample does not independently verify every tablet, package or future production batch.

Vardenafil & Nitrates

One of the most important safety considerations with Vardenafil is its interaction with organic nitrate medicines.

PDE5 inhibition can amplify the blood-pressure-lowering effects of nitrates and potentially cause severe hypotension. Current U.S. prescribing information therefore lists concomitant use of nitrates or nitric oxide donors as contraindicated.

Medication history is therefore an essential consideration when Vardenafil or another PDE5 inhibitor is being evaluated medically.

Vardenafil & QT Prolongation

A particularly important safety consideration that distinguishes Vardenafil within the PDE5 inhibitor category is its relationship with the QT interval, an electrical measurement associated with cardiac rhythm.

Current prescribing information advises that people with congenital QT prolongation and those using certain Class IA or Class III antiarrhythmic medicines should avoid Vardenafil.

This makes cardiac medication history particularly relevant when comparing Vardenafil with other erectile-dysfunction medicines. Sharing the PDE5 inhibitor classification does not mean that Sildenafil, Tadalafil, Avanafil and Vardenafil have identical electrophysiological precautions.

Drug Interactions Matter

Vardenafil can interact with medicines that affect blood pressure or its metabolism. Alpha-blockers and antihypertensive medicines can contribute to additional blood-pressure lowering.

Medicines that strongly inhibit CYP3A4 can also increase Vardenafil exposure. Antiarrhythmic medications are particularly important because of the QT-related considerations associated with Vardenafil.

A complete medication list therefore provides substantially more useful safety information than tablet strength alone.

Vardenafil Safety Information

Vardenafil is a pharmacologically active prescription medicine. Adverse effects associated with PDE5 inhibition can include headache, flushing, nasal congestion and indigestion.

Because sexual activity increases cardiovascular workload, underlying cardiovascular health is relevant when erectile-dysfunction treatment is being considered.

Vardenafil also has important QT-related precautions that can make certain cardiac conditions or antiarrhythmic medicines particularly relevant.

Rare but serious events associated with PDE5 inhibitors can include prolonged erection, sudden changes in vision and sudden hearing changes. Symptoms of this type require prompt medical evaluation.

A published laboratory report can provide information about an analyzed product sample but does not establish that taking Vardenafil is medically appropriate or safe for an individual. This category is intended for product identification and comparison and does not provide individualized erectile-dysfunction or dosing guidance.

Priapism Requires Medical Attention

An erection that persists for several hours can represent priapism, a medical emergency because prolonged impairment of normal blood flow can damage erectile tissue.

An erection lasting more than four hours requires immediate medical assessment. A prolonged erection should not be interpreted as evidence that a Vardenafil product is particularly strong or high quality.

Vision & Hearing Warnings

Rare but serious visual and hearing-related events have been reported in association with PDE5 inhibitors. Sudden loss or significant reduction of vision or hearing warrants prompt medical evaluation.

Existing cardiovascular, ophthalmic or hearing-related conditions can influence individual risk and should be considered as part of appropriate medical assessment.

Vardenafil Does Not Increase Libido

Vardenafil supports the physiological erectile response when sexual stimulation occurs. It does not primarily increase sexual desire.

Low libido and erectile dysfunction can have different causes. A PDE5 inhibitor may improve erectile function without correcting low desire related to hormones, medications, psychological factors or other conditions.

Is Vardenafil a Testosterone Product?

No. Vardenafil is not Testosterone and is not an anabolic-androgenic steroid.

Low Testosterone can contribute to sexual symptoms in some individuals, but Vardenafil works through PDE5 inhibition and vascular signaling rather than supplying or replacing testosterone.

This distinction is useful within a catalog that includes both hormonal products and sexual-health medicines.

Vardenafil Does Not Prevent STIs

Vardenafil does not protect against sexually transmitted infections and does not function as contraception.

Improving erectile function does not change the need for appropriate safer-sex practices or contraception where relevant.

USA Domestic & International Availability

Vardenafil products may be available from the USA Domestic Warehouse, the International Warehouse, or both. Available manufacturers, dosage forms, tablet strengths and stock levels can differ between warehouse locations.

For delivery within the United States, USA Domestic shipments typically take 4–5 business days after dispatch, while International Warehouse shipments typically take 15–20 business days after dispatch.

Delivery estimates begin after dispatch and do not include order processing time. Additional delivery, tracking and reship information is available on the Shipping Information page.

Product & Payment Information

Bitcoin and other supported cryptocurrencies are available at checkout. When comparing Vardenafil products, review the manufacturer, dosage form, labeled tablet strength, package quantity, current price, available laboratory reports and warehouse location.

Payment options and warehouse availability do not determine whether Vardenafil is medically appropriate for an individual. Where the store's separate crypto discount applies, eligibility depends on the current pricing status of the product.